Progen Pharmaceuticals Limited - Latest News [Page 1]
Progen Update on Phase 3 Clinical Program
Sunday, 4 November 2007, 2:32 pm | Progen Pharmaceuticals Limited
Progen Pharmaceuticals Limited (ASX: PGL; NASDAQ: PGLA) today announced that in light of the recent Fast Track designation awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence ... More >>
Progen Presents Data For Anti-Tumour Compounds
Wednesday, 24 October 2007, 12:28 am | Progen Pharmaceuticals Limited
Progen Presents Preclinical Data for Second-Generation Anti-Tumour Compounds at AACR-NCI-EORTC International Conference More >>
Leading CRO to Assist Trial of Progen PI-88
Thursday, 16 August 2007, 3:29 pm | Progen Pharmaceuticals Limited
Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 - Planning for Phase 3 Trial Initiation on Track More >>